NCT05223530 Prenatal Programming of Childhood Obesity and Cardio Metabolic Disorders
| NCT ID | NCT05223530 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Helsinki University Central Hospital |
| Condition | Cardiometabolic Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 750 participants |
| Start Date | 2022-02-25 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 750 participants in total. It began in 2022-02-25 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective 11-17 -years follow-up of two existing pregnancy cohort (PREDO) and prevention (RADIEL) studies. The main objective is to investigate the associations between maternal overweight, obesity, hypertensive disorders in pregnancy, gestational diabetes, and maternal-fetal metabolome, child's birth outcomes, and overweight and obesity and cardio metabolic health outcomes in childhood and adolescence. During this follow-up study, the mothers and their 11-17-year-old children are invited for a study visit and their cardio metabolic health is studied by many different methods.
Eligibility Criteria
Inclusion Criteria: * all mothers participated originally in the PREDO or the RADIEL studies during pregnancy and with delivery during this index pregnancy Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05223530 clinical trial?
This trial is open to participants of all sexes, aged 11 Years or older, up to 55 Years, studying Cardiometabolic Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05223530 currently recruiting?
Yes, NCT05223530 is actively recruiting participants. Contact the research team at saila.koivusalo@hus.fi for enrollment information.
Where is the NCT05223530 trial being conducted?
This trial is being conducted at Helsinki, Finland.
Who is sponsoring the NCT05223530 clinical trial?
NCT05223530 is sponsored by Helsinki University Central Hospital. The trial plans to enroll 750 participants.